Park Ha Biological Technology Co., Ltd.
PHH
$0.57
-$0.0107-1.84%
NASDAQ
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 764.50K | 764.50K | 426.50K | 426.50K | 543.80K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 764.50K | 764.50K | 426.50K | 426.50K | 543.80K |
| Cost of Revenue | 48.60K | 48.60K | 49.10K | 49.10K | 93.00K |
| Gross Profit | 715.80K | 715.80K | 377.40K | 377.40K | 450.80K |
| SG&A Expenses | 356.90K | 356.90K | 321.20K | 321.20K | 191.10K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 413.80K | 413.80K | 380.30K | 380.30K | 290.90K |
| Operating Income | 350.70K | 350.70K | 46.20K | 46.20K | 252.90K |
| Income Before Tax | 350.10K | 350.10K | 46.60K | 46.60K | 252.00K |
| Income Tax Expenses | 135.20K | 135.20K | 22.20K | 22.20K | 75.90K |
| Earnings from Continuing Operations | 214.80K | 214.80K | 24.50K | 24.50K | 176.10K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 214.80K | 214.80K | 24.50K | 24.50K | 176.10K |
| EBIT | 350.70K | 350.70K | 46.20K | 46.20K | 252.90K |
| EBITDA | 356.40K | 356.40K | 51.80K | 51.80K | 257.90K |
| EPS Basic | 0.01 | 0.01 | 0.00 | 0.00 | 0.01 |
| Normalized Basic EPS | 0.01 | 0.01 | 0.00 | 0.00 | 0.01 |
| EPS Diluted | 0.01 | 0.01 | 0.00 | 0.00 | 0.01 |
| Normalized Diluted EPS | 0.01 | 0.01 | 0.00 | 0.00 | 0.01 |
| Average Basic Shares Outstanding | 25.00M | 25.00M | 25.00M | 25.00M | 25.00M |
| Average Diluted Shares Outstanding | 25.00M | 25.00M | 25.00M | 25.00M | 25.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |